Download Vasculitis and Connective Tissue Disease

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Vasculitis and connective
tissue disease – just a taster!!
The common and the rare!!
Polymyalgia rheumatica (PMR)
• Common clinical syndrome of middleaged & elderly (2-3 / GP)
• characterized by pain & stiffness neck,
shoulder & pelvic girdles
•
• dramatic response to small doses of
steroids
Giant cell arteritis
• vasculitis underlying polymyalgia
rheumatica and temporal arteritis
• Other terms cranial arteritis &
granulomatous arteritis
•
• Early recognition & treatment can
prevent blindness & other
complications resulting from occlusion
or rupture of involved arteries
Polymyalgia rheumatica
• musculoskeletal symptoms usually bilateral & symmetric
• Stiffness predominant feature; particularly EMS may prevent patient
getting out of bed
•
• Muscular pain often diffuse; pain at night common
• Corticosteroid treatment usually required for at least 2 years.
Sometimes 4-5 years
• Systemic features include low-grade fever, fatigue, weight loss & an
increased erythrocyte sedimentation rate
• Prednisolone 20 – 30mg / day ( tapering over 2 years or
so)
Giant cell arteritis
• wide range of symptoms, clinical findings
related to involved arteries
• Frequently fatigue, headaches, jaw
claudication, loss of vision, scalp
tenderness, AND polymyalgia rheumatica
• Risk is loss of vision – this is a medical
emergency!
• Prednisolone 40 – 60 mg / day ( tapering over 2
years or so)
Downloaded from: Rheumatology (on 19 November 2006 12:03 AM)
© 2005 Elsevier
Downloaded from: Rheumatology (on 19 November 2006 12:03 AM)
© 2005 Elsevier
Figure 157.2 Granulomatous vasculitis. (a) Brain biopsy findings of granulomatous vasculitis side by side with a polyarteritis-type necrotizing arteritis (open arrow). (b)
Close-up view of (a) showing foreign body (short arrow) & foreign body (long arrow) giant cells in granulomatous vasculitis. Hematoxylin & eosin, × 64 & 400
respectively. (With permission from Calabrese et al. 4)
Downloaded from: Rheumatology (on 18 November 2006 12:39 PM)
© 2005 Elsevier
'vasculitis'
• heterogeneous group of disorders characterized
inflammatory alteration of blood vessel wall
• primary event (primary vasculitis) - e.g. in ANCAassociated vasculitides
• or secondary to other diseases (secondary
vasculitis), e.g. in RA or SLE
• underlying events mediated by immunologic
mechanisms
• supported by response to various potent
immunosuppressives
• Aggressive treatment to prevent permanent organ
damage
Few clues to aetiology of primary
vasculitides
• Hep B virus implicated as causative agent in
polyarteritis nodosa (PAN) & Hep C in essential mixed
cryoglobulinemia (EMC)
•
• circumstantial evidence for causative role of infection in
Wegener's granulomatosis: seasonal variation in
incidence of proteinase 3 autoantibodies (PR3-ANCA)
suggests that an infectious agent prevalent in spring or
autumn might trigger WG
• genetic predisposition suggested by studies showing link
between small vessel vasculitis & HLA-DQw7, between
WG & DR1, & between HLA-Bw52 & giant cell arteritis
•
•
•
•
•
•
•
•
•
•
•
To name a few……..
Giant cell arteritis
Takayasu arteritis
Polyarteritis nodosa
Kawasaki disease
Wegeners Granulomatosis
Churg-Strauss Syndrome
Microscopic polyangiitis
Henoch-Schonlein purpura
Essential cryoglobulinaemic vasculitis
Behcets disease
Cutaneous leukocytoclastic vasculitis
Downloaded from: Rheumatology (on 19 November 2006 12:03 AM)
© 2005 Elsevier
Figure 155.6 Leukocytoclastic vasculitis with ulceration in a patient with rheumatoid arthritis.
Downloaded from: Rheumatology (on 19 November 2006 12:03 AM)
© 2005 Elsevier
Downloaded from: Rheumatology (on 18 November 2006 12:39 PM)
© 2005 Elsevier
Downloaded from: Rheumatology (on 19 November 2006 12:03 AM)
© 2005 Elsevier
Figure 146.4 Polyarteritis involving the gallbladder artery, showing pleomorphic inflammatory cell infiltration & fibrinoid necrosis. (With permission from Conn 10.)
Downloaded from: Rheumatology (on 19 November 2006 12:03 AM)
© 2005 Elsevier
Downloaded from: Rheumatology (on 18 November 2006 12:39 PM)
© 2005 Elsevier
Downloaded from: Rheumatology (on 19 November 2006 12:03 AM)
© 2005 Elsevier
Figure 146.6 Vasculitis pathogenesis
Downloaded from: Rheumatology (on 19 November 2006 12:03 AM)
© 2005 Elsevier
Downloaded from: Rheumatology (on 19 November 2006 12:03 AM)
© 2005 Elsevier
Downloaded from: Rheumatology (on 19 November 2006 12:03 AM)
© 2005 Elsevier
Downloaded from: Rheumatology (on 19 November 2006 12:03 AM)
© 2005 Elsevier
Downloaded from: Rheumatology (on 18 November 2006 12:39 PM)
© 2005 Elsevier
Connective tissue disease
• group of conditions which affect many organs or tissues
• widespread inflammation
• Have some symptoms in common
• All patients have features of general inflammation : fever,
weight loss, tiredness & anaemia
• Most patients also have inflammation of joints
• Vasculitis of small blood vessels also common
• Raynaud’s phenomenon
• Involvement of the kidney may result in hypertension
• If inflammation settles all symptoms improve
• However, if process continues scarring occurs in
affected tissues - will be damaged permanently
• As well as symptoms common to whole
group, each CTD has own particular
symptoms
• All can be distinguished clinically &
serologically
• All these CTD are rare
• All more common in women
• All treated with immunosuppressant drugs
• SCLERODERMA; excessive fibrosis of tissues; skin is
hard, & loses its ability to stretch. The fingertips are
thickened & skin around the mouth tightens
• POLYMYOSITIS; inflammation mainly in muscles; pain &
weakness are main symptoms. Lung fibrosis
• SLE; skin, joints, fatigue, mouth ulcers, alopecia,
glomerulonephritis, lung fibrosis, CNS involvement
• Sjogrens; sicca symptoms, joints, fatigue, lymphoma risk
•
• Also may have symptoms from different disorders;
MIXED CONNECTIVE TISSUE DISEASE
Downloaded from: Rheumatology (on 18 November 2006 12:39 PM)
© 2005 Elsevier
Downloaded from: Rheumatology (on 18 November 2006 12:39 PM)
© 2005 Elsevier
Downloaded from: Rheumatology (on 18 November 2006 12:39 PM)
© 2005 Elsevier
Downloaded from: Rheumatology (on 19 November 2006 12:03 AM)
© 2005 Elsevier
Figure 122.6 Mouth ulcers in a patient with SLE.
Downloaded from: Rheumatology (on 18 November 2006 12:39 PM)
© 2005 Elsevier